Treating Migraines during a pregnancy has been a big problem for many women. All of the current Migraine abortives are FDA pregnancy C, which means one of two things:
- animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women - or -
- animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus.
The manufacturer of Imitrex (sumatriptan, now available as generic) and Amerge (naratriptan), GlaxoSmithKline, has been monitoring any effects on children whose mothers took Imitrex or Amerge during pregnancy.
To find out what researchers have concluded about the safety of taking Imitrex or Amerge, read Migraines, Triptan Safety, and Pregnancy.